Robotic mitral valve repair in octogenarians significantly reduced postoperative hospital stay compared to conventional repair (12 vs. 13 days, P=0.04) with comparable 30-day mortality.
Cohort (n=53)
No
Is robotic mitral valve repair safe and feasible in patients aged ≥80 years with degenerative mitral regurgitation?
This study investigates the safety and feasibility of robotic mitral valve repair in octogenarians with degenerative mitral regurgitation.
Absolute Event Rate: 12% vs 13%
p-value: p=0.04
Background: Robotic mitral valve repair (r-MVr) offers potential advantages, but its safety and feasibility in patients aged ≥80 years remain unclear.
Machii et al. (Fri,) conducted a cohort in Degenerative mitral regurgitation (n=53). Robotic mitral valve repair (r-MVr) vs. Conventional mitral valve repair (c-MVr) was evaluated on Postoperative hospital stay (days) (p=0.04). Robotic mitral valve repair in octogenarians significantly reduced postoperative hospital stay compared to conventional repair (12 vs. 13 days, P=0.04) with comparable 30-day mortality.